Everything Is a Signal: Sahir Ali on Connecting AI, Biology, and Venture Capital

In Precision Signals, Sean Khozin sits down with Sahir Ali, Founder and Managing Partner of Modi Ventures, to explore the uncommon path that led him from engineering and quantitative finance into cancer research and technology investing.

Sahir explains how his BioStack framework applies portfolio theory to private biotech investing, why first-principles thinking matters more than hype, and where artificial intelligence is genuinely transforming medicine—and where it is not.

Watch the whole Precision Signals episode here.

Next
Next

Generate: Biomedicines Clocks Largest IPO Since 2024 with $400M Raise